13D Filing: OrbiMed Advisors and Roka Bioscience Inc. (ROKA)

Page 10 of 10

Page 10 of 10 – SEC Filing

Schedule II
The business and operations of OrbiMed Capital GP III LLC are managed by the executive officers and directors of its managing member, OrbiMed Advisors LLC, set forth on Schedule I attached hereto.
EXHIBIT INDEX
Exhibit
Description
1.
Joint Filing Agreement among OrbiMed Advisors LLC, OrbiMed Capital GP III LLC and Samuel D. Isaly.

Follow Roka Bioscience Inc. (NASDAQ:ROKA)

Page 10 of 10